Corbin Thompson

Title: Corbin Thompson: Innovator in JAK Inhibitor Research

Introduction

Corbin Thompson is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceutical research, particularly in the development of JAK inhibitors. With a total of five patents to his name, Thompson's work is paving the way for new treatments in respiratory diseases.

Latest Patents

Thompson's latest patents include innovative compounds that serve as JAK kinase inhibitors. One of his inventions, titled "Dimethyl amino azetidine amides as JAK inhibitors," provides compounds that are useful in treating respiratory diseases. The invention outlines pharmaceutical compositions comprising these compounds and methods for their application. Another significant patent is "5 to 7 membered heterocyclic amides as JAK inhibitors," which similarly focuses on compounds that can be utilized as JAK kinase inhibitors for therapeutic purposes.

Career Highlights

Corbin Thompson is currently associated with Theravance Biopharma R&D IP, LLC, where he continues to advance his research in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for respiratory conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Thompson collaborates with talented individuals in his field, including coworkers Daniel D. Long and Cameron Smith. Their combined expertise contributes to the innovative research environment at Theravance Biopharma.

Conclusion

Corbin Thompson's contributions to the field of JAK inhibitors highlight his role as a leading inventor in pharmaceutical research. His innovative patents and collaborative efforts are instrumental in the ongoing development of treatments for respiratory diseases.